Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Coloplast

635.6

 

DKK

 

-1.09 %

Less than 1K followers

COLO B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Investor consensus
Compare
-1.09%
-12.36%
-18.13%
-19.16%
-29.97%
-26.02%
-20.71%
-40.04%
+1,255.22%

Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Read more
Market cap
145.04B DKK
Turnover
401.68M DKK
Revenue
27.03B
EBIT %
27.08 %
P/E
28.3
Dividend yield-%
3.46 %
Financial calendar
19/8
2025

Interim report Q3'25

4/11
2025

Annual report '25

4/12
2025

General meeting '25

All
Press releases
ShowingAll content types
Regulatory press release5/8/2025, 12:42 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release5/6/2025, 5:29 AM

Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25

Coloplast
Regulatory press release5/5/2025, 3:11 PM

Coloplast A/S CEO Kristian Villumsen steps down as of today

Coloplast

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/1/2025, 10:23 AM

Coloplast A/S Revised guidance for FY 2024/25

Coloplast
Press release4/15/2025, 12:04 PM

Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST

Coloplast
Regulatory press release2/4/2025, 12:12 PM

Coloplast A/S - Allocation of Share Options

Coloplast
Regulatory press release2/4/2025, 6:29 AM

Coloplast A/S - Interim Financial Report, Q1 2024/25

Coloplast
Press release1/22/2025, 9:32 AM

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction)

Coloplast
Press release1/21/2025, 2:08 PM

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET

Coloplast
Regulatory press release12/11/2024, 2:54 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release12/5/2024, 4:11 PM

Coloplast A/S - Decisions at the Annual General Meeting 2024

Coloplast
Press release12/4/2024, 12:01 PM

Coloplast divests core Skin Care product portfolio

Coloplast
Press release11/14/2024, 1:22 PM

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy

Coloplast
Regulatory press release11/12/2024, 11:00 AM

Coloplast A/S - Notice of Annual General Meeting 2024

Coloplast
Regulatory press release11/5/2024, 6:28 AM

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

Coloplast
Regulatory press release11/5/2024, 6:26 AM

Coloplast A/S - Full-Year Financial Results 2023/24

Coloplast
Regulatory press release11/5/2024, 6:00 AM

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

Coloplast
Press release10/21/2024, 1:09 PM

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

Coloplast
Regulatory press release9/25/2024, 1:02 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release9/25/2024, 12:29 PM

Coloplast A/S - Financial Calendar 2024-25

Coloplast
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team